Literature DB >> 24522294

Single human papillomavirus 16 or 52 infection and later cytological findings in Japanese women with NILM or ASC-US.

Shuhei Abe1, Kiyonori Miura1, Akira Kinoshita2, Hiroyuki Mishima2, Shoko Miura1, Kentaro Yamasaki1, Yuri Hasegawa1, Ai Higashijima1, Ozora Jo1, Atsushi Yoshida1, Masanori Kaneuchi1, Koh-Ichiro Yoshiura2, Hideaki Masuzaki1.   

Abstract

The relationship between oncogenic human papillomavirus (HPV) infection and later cytological findings in the uterine cervix is unknown in women who were negative for intraepithelial lesion and malignancy (NILM) or atypical squamous cells of undetermined significance (ASC-US). This was investigated in this study in a Japanese population to determine the clinical utility of oncogenic (HPV) genotyping. The relative risk of progressive cytological findings 2 years after identification of oncogenic HPV infection was higher than in cases of non-oncogenic HPV infection (relative risk 3.827; 95% confidence interval (CI): 1.282-11.422), as well as in cases of negative HPV infection (relative risk 2.124; 95% CI: 1.451-3.110). Moreover, the relative risk of progression of cytological findings 2 years later in cases of HPV-16 infection was higher than in cases of HPV-52 infection (relative risk 2.094; 95% CI: 1.005-3.935). Therefore, the initial HPV-DNA genotype may be a potential predictive marker of later progression of cytological findings in the uterine cervix in cases of NILM or ASC-US.

Entities:  

Mesh:

Year:  2014        PMID: 24522294     DOI: 10.1038/jhg.2014.9

Source DB:  PubMed          Journal:  J Hum Genet        ISSN: 1434-5161            Impact factor:   3.172


  22 in total

1.  Improved amplification of genital human papillomaviruses.

Authors:  P E Gravitt; C L Peyton; T Q Alessi; C M Wheeler; F Coutlée; A Hildesheim; M H Schiffman; D R Scott; R J Apple
Journal:  J Clin Microbiol       Date:  2000-01       Impact factor: 5.948

2.  Human papillomavirus is a necessary cause of invasive cervical cancer worldwide.

Authors:  J M Walboomers; M V Jacobs; M M Manos; F X Bosch; J A Kummer; K V Shah; P J Snijders; J Peto; C J Meijer; N Muñoz
Journal:  J Pathol       Date:  1999-09       Impact factor: 7.996

3.  Evaluation of HPV-16 and HPV-18 genotyping for the triage of women with high-risk HPV+ cytology-negative results.

Authors:  Thomas C Wright; Mark H Stoler; Abha Sharma; Guili Zhang; Catherine Behrens; Teresa L Wright
Journal:  Am J Clin Pathol       Date:  2011-10       Impact factor: 2.493

4.  HLA class II DRB1*1302 allele protects against progression to cervical intraepithelial neoplasia grade 3: a multicenter prospective cohort study.

Authors:  Koji Matsumoto; Hiroo Maeda; Akinori Oki; Naoyoshi Takatsuka; Toshiharu Yasugi; Reiko Furuta; Ranko Hirata; Akira Mitsuhashi; Takuma Fujii; Yasuo Hirai; Tsuyoshi Iwasaka; Nobuo Yaegashi; Yoh Watanabe; Yutaka Nagai; Tomoyuki Kitagawa; Hiroyuki Yoshikawa
Journal:  Int J Gynecol Cancer       Date:  2012-03       Impact factor: 3.437

5.  Adoption of HPV testing as an adjunct to conventional cytology in cervical cancer screening in Japan.

Authors:  Masaki Inoue; Makoto Okamura; Shigeru Hashimoto; Masahiro Tango; Toshihiko Ukita
Journal:  Int J Gynaecol Obstet       Date:  2010-08-12       Impact factor: 3.561

6.  Human papillomavirus (HPV) DNA triage of women with atypical squamous cells of undetermined significance with Amplicor HPV and Hybrid Capture 2 assays for detection of high-grade lesions of the uterine cervix.

Authors:  Simon Dufresne; Philippe Sauthier; Marie-Hélène Mayrand; Patrick Petignat; Diane Provencher; Pierre Drouin; Philippe Gauthier; Marie-Josée Dupuis; Bertrand Michon; Stéphan Ouellet; Rachid Hadjeres; Alex Ferenczy; Eduardo L Franco; François Coutlée
Journal:  J Clin Microbiol       Date:  2010-11-17       Impact factor: 5.948

7.  Heritability of cervical tumours.

Authors:  P K Magnusson; P Lichtenstein; U B Gyllensten
Journal:  Int J Cancer       Date:  2000-12-01       Impact factor: 7.396

8.  Initial viral load in cases of single human papillomavirus 16 or 52 persistent infection is associated with progression of later cytopathological findings in the uterine cervix.

Authors:  Daisuke Hamaguchi; Kiyonori Miura; Shuhei Abe; Akira Kinoshita; Shoko Miura; Kentaro Yamasaki; Koh-ichiro Yoshiura; Hideaki Masuzaki
Journal:  J Med Virol       Date:  2013-08-19       Impact factor: 2.327

9.  A large case-control study of cervical cancer risk associated with human papillomavirus infection in Japan, by nucleotide sequencing-based genotyping.

Authors:  Tsuyoshi Asato; Toshiyuki Maehama; Yutaka Nagai; Koji Kanazawa; Hiroshi Uezato; Ken-Ichi Kariya
Journal:  J Infect Dis       Date:  2004-04-26       Impact factor: 5.226

10.  Quantitative real-time polymerase chain reaction analysis of the type distribution, viral load, and physical status of human papillomavirus in liquid-based cytology samples from cervical lesions.

Authors:  T Yoshida; T Sano; T Kanuma; N Owada; S Sakurai; T Fukuda; T Nakajima
Journal:  Int J Gynecol Cancer       Date:  2007-05-15       Impact factor: 3.437

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.